CREB3L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.78529999567334E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.25849999998984E-06 |
Normal-vs-Stage2 |
1.855770E-03 |
Normal-vs-Stage3 |
1.1883999999629E-06 |
Normal-vs-Stage4 |
4.73029999947805E-07 |
Stage1-vs-Stage2 |
8.694800E-01 |
Stage1-vs-Stage3 |
3.347400E-01 |
Stage1-vs-Stage4 |
1.704040E-01 |
Stage2-vs-Stage3 |
6.401000E-01 |
Stage2-vs-Stage4 |
4.182800E-01 |
Stage3-vs-Stage4 |
6.731400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.27739999975252E-07 |
Normal-vs-AfricanAmerican |
8.03423994000241E-12 |
Normal-vs-Asian |
8.833600E-02 |
Caucasian-vs-AfricanAmerican |
1.207760E-04 |
Caucasian-vs-Asian |
9.710800E-01 |
AfricanAmerican-vs-Asian |
1.045590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.18800000340025E-08 |
Normal-vs-Female |
1.60562000000031E-05 |
Male-vs-Female |
2.750000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.946400E-02 |
Normal-vs-Age(41-60Yrs) |
2.00920000004157E-06 |
Normal-vs-Age(61-80Yrs) |
1.23840000032516E-07 |
Normal-vs-Age(81-100Yrs) |
2.97380000002789E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.999200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.304600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.472800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.347200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.160300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.300200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.440600E-01 |
Normal-vs-Grade 2 |
2.9405000000482E-06 |
Normal-vs-Grade 3 |
1.22650000045077E-07 |
Normal-vs-Grade 4 |
2.16740000003046E-06 |
Grade 1-vs-Grade 2 |
2.689200E-01 |
Grade 1-vs-Grade 3 |
1.542180E-01 |
Grade 1-vs-Grade 4 |
1.057600E-01 |
Grade 2-vs-Grade 3 |
3.348000E-01 |
Grade 2-vs-Grade 4 |
2.200400E-01 |
Grade 3-vs-Grade 4 |
6.095600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.796800E-04 |
Normal-vs-ccB subtype |
1.86385999999539E-05 |
ccA subtype-vs-ccB subtype |
3.460000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.72220000005385E-06 |
Normal-vs-N1 |
5.852200E-01 |
N0-vs-N1 |
1.674560E-01 |
|
|